SPINELLA, AMELIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.303
AS - Asia 5.619
EU - Europa 4.293
SA - Sud America 830
AF - Africa 154
OC - Oceania 22
Continente sconosciuto - Info sul continente non disponibili 12
Totale 20.233
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.088
SG - Singapore 1.798
CN - Cina 1.441
IT - Italia 1.110
GB - Regno Unito 938
HK - Hong Kong 666
BR - Brasile 632
VN - Vietnam 629
SE - Svezia 498
DE - Germania 411
FI - Finlandia 259
FR - Francia 253
RU - Federazione Russa 241
KR - Corea 199
IN - India 195
ID - Indonesia 135
TR - Turchia 123
CA - Canada 105
UA - Ucraina 99
BG - Bulgaria 76
AR - Argentina 75
MX - Messico 74
NL - Olanda 72
JP - Giappone 64
BD - Bangladesh 63
ES - Italia 62
ZA - Sudafrica 54
PL - Polonia 48
PK - Pakistan 44
IQ - Iraq 38
AT - Austria 35
CO - Colombia 30
IE - Irlanda 29
MY - Malesia 29
MA - Marocco 25
AE - Emirati Arabi Uniti 24
LT - Lituania 24
CL - Cile 22
AU - Australia 20
BE - Belgio 20
CZ - Repubblica Ceca 19
EC - Ecuador 19
RO - Romania 18
VE - Venezuela 18
EG - Egitto 17
SA - Arabia Saudita 16
IR - Iran 15
TN - Tunisia 15
PE - Perù 13
UZ - Uzbekistan 13
NP - Nepal 12
TW - Taiwan 12
AL - Albania 11
JO - Giordania 11
KE - Kenya 11
AZ - Azerbaigian 10
TH - Thailandia 10
PH - Filippine 9
EU - Europa 8
IL - Israele 8
OM - Oman 8
PT - Portogallo 8
PY - Paraguay 8
GR - Grecia 7
NG - Nigeria 7
PS - Palestinian Territory 7
BY - Bielorussia 6
BZ - Belize 6
DK - Danimarca 6
HU - Ungheria 6
RS - Serbia 6
UY - Uruguay 6
BH - Bahrain 5
CH - Svizzera 5
CR - Costa Rica 5
DO - Repubblica Dominicana 5
KG - Kirghizistan 5
SY - Repubblica araba siriana 5
DZ - Algeria 4
EE - Estonia 4
ET - Etiopia 4
HR - Croazia 4
LU - Lussemburgo 4
SK - Slovacchia (Repubblica Slovacca) 4
AO - Angola 3
BB - Barbados 3
BO - Bolivia 3
GE - Georgia 3
HN - Honduras 3
KZ - Kazakistan 3
LA - Repubblica Popolare Democratica del Laos 3
MD - Moldavia 3
MV - Maldive 3
PA - Panama 3
TT - Trinidad e Tobago 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AM - Armenia 2
BA - Bosnia-Erzegovina 2
BF - Burkina Faso 2
CG - Congo 2
Totale 20.191
Salva come PNG Salva come JPEG
Città #
Santa Clara 1.153
Singapore 1.123
Ashburn 1.006
Fairfield 669
Hong Kong 658
Chandler 592
San Jose 585
Southend 470
Hefei 439
Woodbridge 321
Houston 311
Nyköping 266
Seattle 265
London 251
Beijing 228
Wilmington 223
Council Bluffs 203
Cambridge 200
Ho Chi Minh City 195
Helsinki 192
Seoul 189
Los Angeles 179
The Dalles 166
New York 164
Hanoi 163
Jacksonville 144
Ann Arbor 140
Dearborn 133
San Diego 123
Chicago 122
Bologna 111
Modena 111
Jakarta 110
Milan 99
Lauterbourg 85
Sofia 74
Princeton 71
Munich 70
Bremen 69
São Paulo 69
Shanghai 66
Orem 64
Atlanta 60
Moscow 59
Buffalo 53
Frankfurt am Main 53
Izmir 51
Tokyo 49
Dallas 47
Warsaw 40
Salt Lake City 39
Denver 35
Johannesburg 35
Parma 35
Redwood City 32
Florence 31
Poplar 30
Mexico City 29
Montreal 29
Turku 29
Chennai 28
Eugene 28
Haiphong 28
New Delhi 28
Phoenix 28
Rome 28
Stockholm 28
Guangzhou 27
Columbus 26
Da Nang 26
Ovada 25
Reggio Emilia 25
Kent 24
Lappeenranta 24
Amsterdam 23
Delhi 23
Toronto 23
Ottawa 22
Nuremberg 21
Redondo Beach 21
Paris 20
Portsmouth 20
Rio de Janeiro 19
Brussels 18
Hillsboro 18
Ankara 17
Dublin 17
Falls Church 17
Mumbai 17
Naples 17
Elk Grove Village 16
Manchester 15
San Francisco 15
Belo Horizonte 14
Boston 14
Brooklyn 14
Baghdad 13
Boardman 13
Nanjing 13
Porto Alegre 13
Totale 13.434
Salva come PNG Salva come JPEG
Nome #
Systemic sclerosis progression INvestiGation (SPRING) Italian registry: Demographic and clinico-serological features of the scleroderma spectrum 403
Systemic sclerosis evolution of disease pathomorphosis and survival. Our experience on Italian patients' population and review of the literature 347
COVID-19 and rheumatic autoimmune systemic diseases: report of a large Italian patients series 344
Cardio-pulmonary disease management in patients with systemic sclerosis: cardio-rheumatology clinic and patient care standardisation proposal 320
Elevated Troponin Serum Levels in Adult Onset Still's Disease 319
Acute exacerbation of interstitial lung diseases secondary to systemic rheumatic diseases: A prospective study and review of the literature 319
Established coronary artery disease in systemic sclerosis compared to type 2 diabetic female patients: a cross-sectional study 318
Serum 25-OH vitamin D levels in systemic sclerosis: analysis of 140 patients and review of the literature 317
Cardiac involvement in systemic sclerosis: identification of high-risk patient profiles in different patterns of clinical presentation 317
Cryoglobulin evaluation: analysis of intra-laboratory and inter-laboratory variability 308
Efficacy of Belimumab for active lupus nephritis in a young Hispanic woman intolerant to standard treatment: a case report 306
The discrepancy between clinical and ultrasonographic remission in rheumatoid arthritis is not related to therapy or autoantibody status. 305
Unusual association between Budd–Chiari syndrome secondary to antiphospholipid syndrome and relapsing polychondritis: a case report and review of the literature 305
Large Vessel Vasculitis Occurring in Rheumatoid Arthritis Patient under Anti-TNF Therapy 294
Long-term treatment with rituximab in interstitial lung disease related to systemic sclerosis: our clinical experience 280
Ultrasonography involvement of carotid, upper and lower limb arteries in a large cohort of systemic sclerosis patients 278
Management of cardiopulmonary disease in patients with systemic sclerosis: cardiorheumatology clinic and patient care standardization proposal 272
Beyond cat scratch disease: a case report of bartonella infection mimicking vasculitic disorder 266
CLINICAL AND PATHOLOGICAL FEATURES OF BREAST CANCER IN PATIENTS WITH SYSTEMIC SCLEROSIS: PRELIMINARY DATA FROM THE SCLERO-BREAST STUDY 259
Use of Neem oil and Hypericum perforatum for treatment of calcinosis-related skin ulcers in systemic sclerosis 254
UNCLASSIFIABLE INTERSTITIAL LUNG DISEASE OR UNDIFFERENTIATED CONNECTIVE TISSUE DISEASE? A CHALLENGING DIFFERENTIAL DIAGNOSIS 251
Autologous Fat Grafting for the Oral and Digital Complications of Systemic Sclerosis: Results of a Prospective Study 248
The safety of iloprost in systemic sclerosis in a real-life experience 246
Clinical and Pathological Features of Breast Cancer in Systemic Sclerosis: Results from the Sclero-Breast Study 246
Advanced oxidation protein products in serum of patients with systemic sclerosis: a possible indicator of clinical evolution 244
INTERSTITIAL LUNG DISEASE IS ASSOCIATED TO INFECTIONS OF LOWER RESPIRATORY TRACT IN IMMUNOCOMPROMISED RHEUMATOID ARTHRITIS PATIENTS 243
The prevalence of asymptomatic early sacroiliitis in Crohn’s disease patients: The single experience of an Italian tertiary care centre 239
Photobiomodulation Therapy: A New Light in the Treatment of Systemic Sclerosis Skin Ulcers 228
Autologous fat grafting in the treatment of a scleroderma stump-skin ulcer: a case report 226
AB0611 STRAIN ANALYSIS OF THE RIGHT VENTRICLE USING 2D-SPECKLE TRACKING ECHOCARDIOGRAPHY IN A COHORT OF PATIENTS WITH SYSTEMIC SCLEROSIS 224
DANCE CLASS DEDICATED TO SCLERODERMA PATIENTS: JOINT EVALUATION, FUNCTIONAL AND QUALITY OF LIFE BEFORE AND AFTER TREATMENT – CLINICAL TRIAL 223
The profiling of axial spondyloarthritis patient candidate to a biologic therapy: Consensus from a Delphi-panel of Italian experts 223
Assessing hand grasp in patients with systemic sclerosis using the 16-grasp test: Preliminary results from a multidisciplinary study group 222
Erratum: Acute exacerbation of interstitial lung diseases secondary to systemic rheumatic diseases: A prospective study and review of the literature (Journal of Thoracic Disease (2019) 11 (1621-1628) DOI: 10.21037/jtd.2019.03.28) 219
Procedural pain management in the treatment of scleroderma digital ulcers 218
SEVERE VITAMIN D DEFICIENCY IN SYSTEMIC SCLEROSIS 215
DIGITAL NECROSIS IN SYSTEMIC SCLEROSIS NOT ONLY A MICROVASCULAR DISEASE: A CASE REPORT 213
PREVALENCE OF ULTRASOUND ABNORMALITIES IN PATIENTS WITH PSORIATIC ARTHRITIS IN A CLINICAL PHASE OF MINIMAL DISEASE ACTIVITY UNDER ANTI-TNF TREATMENT 213
Invited Response on: Comments on "Autologous Fat Grafting for the Oral and Digital Complications of Systemic Sclerosis: Results of a Prospective Study" 213
COVID-19 and systemic sclerosis: clinicopathological implications from Italian nationwide survey study 213
NATURAL HISTORY OF CRYOGLOBULINEMIA FROM 2000 TO 2018 FROM THE LABORATORY POINT OF VIEW: AN ANALYSIS OF CRYOGLOBULIN CHARACTERISTICS IN A SINGLE CENTER. 211
The predictive role of the TAPSE/sPAP ratio for cardiovascular events and mortality in systemic sclerosis with pulmonary hypertension 200
COVID-19 in Italian patients with rheumatic autoimmune systemic diseases 200
AB0724 Cardio-pulmonary disease management in patients with systemic sclerosis: cardio-rheumatology clinic and patient care standardisation proposal 198
AB0645 CANNABINOIDS IN THE TREATMENT OF PAIN RELATED TO SYSTEMIC SCLEROSIS SKIN ULCERS: OUR EXPERIENCE 196
Impaired immunogenicity to COVID-19 vaccines in autoimmune systemic diseases. High prevalence of non-response in different patients’ subgroups 196
Covid-19 And Rheumatic Autoimmune Systemic Diseases: Role of Pre-Existing Lung Involvement and Ongoing Treatments 196
Thu0349 autologous fat grafting in the treatment of patients with systemic sclerosis: current experience and future prospects 194
AB0760 Advanced oxidation protein products in serum of patients with systemic sclerosis: a possible indicator of clinical evolution 193
Management of Systemic Sclerosis Patients in the COVID-19 Era: The Experience of an Expert Specialist Reference Center 190
Systemic sclerosis cutaneous expression: Management of skin fibrosis and digital ulcers 187
Promising use of filgotinib in patients affected by systemic sclerosis: Preliminary data from a case series of 5 patients 187
ORAL MANIFESTATIONS IN SYSTEMICSCLEROSIS: CLINICAL EVALUATION OF APERSONAL CASE SERIES OF 13 SCLERODERMAPATIENTS 186
Molecular Pathways of Breast Cancer in Systemic Sclerosis: Exploratory Immunohistochemical Analysis from the Sclero-Breast Study 184
Impegno cardiaco nella sclerosi sistemica 184
Living with arthritis: a “training camp” for coping with stressful events? A survey on resilience of arthritis patients following the COVID-19 pandemic 183
Peripheral Microangiopathy Changes in Pulmonary Arterial Hypertension Related to Systemic Sclerosis: Data From a Multicenter Observational Study 182
AB0212 LONG-TERM TREATMENT WITH RITUXIMAB IN SYSTEMIC SCLEROSISMANAGEMENT: AN OVERVIEW OF THE CLINICAL EXPERIENCE FROM A REAL-LIFE SETTING 181
One-year clinical experience on the use of Nintedanib in Systemic Sclerosis 180
Altered pathways of keratinization, extracellular matrix generation, angiogenesis, and stromal stem cells proliferation in patients with systemic sclerosis 179
Pulmonary arterial hypertension: Guidelines and unmet clinical needs 179
EFFICACY OF CERTOLIZUMAB PEGOL FOR DISEASE CONTROL OF PATIENTS AFFECTED BY ENTEROPATHIC SPONDYLARTHRITIS FOLLOWED BY THE JOINT GASTRO-RHEUMATOLOGICAL CLINIC 175
Cryofibrinogen: A possibile risk factor in systemic sclerosis 173
THU0600 a case of systemic sclerosis complicated by renal crisis: potential etiopathogenetic role of cytomegalovirus and treatment 173
From Localized Scleroderma to Systemic Sclerosis: Coexistence or Possible Evolution 169
Cryoproteinemia: new frontiers for clinicians and the laboratory 167
THE PREDICTIVE ROLE OF THE TAPSE/sPAP RATIO FOR CARDIOVASCULAR EVENTS AND MORTALITY IN SYSTEMIC SCLEROSIS COMPLICATED BY PULMONARY HYPERTENSION 163
POS0837 THE USE OF CANNABIDIOL IN THE TREATMENT OF PAIN RELATED TO SCLERODERMA DIGITAL ULCERS 162
A CALL FOR A COMPREHENSIVE ROLE DEFINITION OF THE STUDY COORDINATOR IN RHEUMATOLOGICAL CLINICAL STUDIES 160
IS THERE A DISSOCIATION BETWEEN CLINICAL REMISSION AND ULTRASONOGRAPHIC ASSESSMENT IN RHEUMATOID ARTHRITIS? 158
PROBABILITÀ DI SIEROCONVERSIONE DEL TEST QUANTIFERON DURANTE LA TERAPIA BIOTECNOLOGICA: DATI PRELIMINARI DI UNO STUDIO RETROSPETTIVO CONDOTTO PRESSO L’ARTHRITIS CLINIC DELL’AZIENDA OSPEDALIERO-UNIVERSITARIA POLICLINICO DI MODENA 156
ACCERTAMENTO DELLA DISABILITÀ NELLE MALATTIE REUMATOLOGICHE (EX L.R. N.4 DEL 19 FEBBRAIO 2008) PROPOSTA DI PROTOCOLLO ORGANIZZATIVO 156
Organic-inorganic materials through first simultaneous frontal polymerization and frontal geopolymerization 155
Covid-19 vaccine hesitancy in systemic sclerosis 152
Erratum: Unusual association between Budd-Chiari syndrome secondary to antiphospholipid syndrome and relapsing polychondritis: A case report and review of the literature (Clinical Rheumatology (2013) 32 (905-907) DOI: 10.1007/s10067-013-2229-z) 151
SAT0285 EVALUATION OF CHRONIC PAIN IN PATIENTS WITH SYSTEMIC SCLEROSIS COMPARED TO THOSE WITH CHRONIC HEADACHE AND RHEUMATOID ARTHRITIS 151
Resilience of systemic sclerosis patients following the first COVID-19 wave in Italy 149
JANUS KINASES INHIBITORS IN CLINICAL PRACTICE IN ITALY. RESULTS FROM A SINGLE CENTER EXPERIENCE 148
A New Promising Role for Selexipag in the Treatment of Scleroderma Vasculopathy: Preliminary Results From a Third Level Italian Scleroderma Center 142
Sex-related Differences in Systemic Sclerosis: A Multicenter Cross-sectional Study From the National Registry of the Italian Society for Rheumatology 138
Letters to the Editors 135
FRI0442 Long-term treatment with rituximab in interstitial lung disease related to systemic sclerosis: our clinical experience 135
Erratum: From Localized Scleroderma to Systemic Sclerosis: Coexistence or Possible Evolution (Dermatology Research and Practice (2018) 2018 (1284687) DOI: 10.1155/2018/1284687) 134
Long-term retention rate, adverse event temporal patterns and rescue treatment strategies of mycophenolate mofetil in systemic sclerosis: insights from real-life 132
Real life use of prostacyclin analog (Iloprost), a multi-centric survey data from the scleroderma study group Emilia Romagna (Sclero-RER) and review of the literature 131
Role of COVID-19 in the progression of scleroderma interstitial lung disease and new onset pulmonary hypertension: a challenging case report. 127
Secondary cryofbrinogenemia is related to more severe microangiopathic involvement in systemic sclerosis: results from a retrospective observational study 126
L’IPERTENSIONE POLMONARE: DALLE NUOVE LINEE GUIDA ALLA PRATICA CLINICA 125
Secondary cryofibrinogenemia is related to more severe microangiopathic involvement in systemic sclerosis: results from a retrospective observational study. 117
Infections of scleroderma digital ulcers: A single center cohort retrospective study 116
BMP-4 and fetuin A in systemic sclerosis patients with or without calcinosis 112
Clinical and ultrasonographic predictors of disease activity after TNF-α inhibitor spacing in patients with psoriatic arthritis 110
Real-life efficacy and safety of nintedanib in systemic sclerosis-interstitial lung disease: data from an Italian multicentre study 103
Significant nailfold capillary loss and late capillaroscopic pattern are associated with pulmonary arterial hypertension in systemic sclerosis 103
The importance of body image and aesthetic medicine in systemic sclerosis 102
OP0063 QUANTITATIVE COMPUTED TOMOGRAPHY PREDICTS 10-YEAR MORTALITY IN INTERSTITIAL LUNG DISEASE RELATED TO SYSTEMIC SCLEROSI 102
Pulmonary Arterial Hypertension Incidence in Patients With Systemic Sclerosis Treated With Bosentan for Digital Ulcers: Evidence From the SPRING-SIR Registry. 94
Prevalence and clinical relevance of digital ulcers in systemic sclerosis patients from the real-life: the experience of the SPRING Registry of the Italian Society for Rheumatology 94
From Raynaud Phenomenon to Systemic Sclerosis in COVID-19: A Case Report 94
Impact of COVID-19 and vaccination campaign on 1,755 systemic sclerosis patients during first three years of pandemic. Possible risks for individuals with impaired immunoreactivity to vaccine, ongoing immunomodulating treatments, and disease-related lung involvement during the next pandemic phase 87
Totale 19.961
Salva come PNG Salva come JPEG
Categoria #
all - tutte 78.701
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 78.701
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021297 0 0 0 0 0 0 0 0 0 82 149 66
2021/20221.565 86 64 109 127 75 130 45 108 175 136 326 184
2022/20231.671 216 207 116 147 205 210 69 151 220 25 53 52
2023/20241.162 42 69 52 168 204 91 91 111 31 40 98 165
2024/20254.633 139 77 91 311 851 734 369 268 532 215 413 633
2025/20267.960 618 317 633 1.104 1.366 622 1.130 435 853 882 0 0
Totale 20.443